医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Mannatech Announces Launch of Brain-supporting Cognitate™ Supplement in Korea

2015年10月06日 PM11:00
このエントリーをはてなブックマークに追加


 

COPPELL, Texas

Mannatech, Incorporated (NASDAQ: MTEX), the founder of the M5M (Mission 5 Million) Foundation, the pioneer of nutritional glycobiology and the global innovator of naturally sourced supplements based on Real Food Technology® solutions, announced its newest brain health product, Cognitate, will launch on October 31 in Korea.

Mannatech’s Cognitate supplement is specially designed to support the brain. The unique formulation helps facilitate the activity of neurotransmitters, which are involved in learning and memory. Cognitate specifically helps to improve cognitive ability. It helps to improve memory and protects against age-related cognitive decline.*

“Mannatech is proud to deliver Cognitate to the people of Korea,” said Mannatech CEO and President, Al Bala. “It is our goal as a company to provide people around the world with state-of-the-art nutritional supplements that will improve their health and wellness in every aspect. Cognitate provides a safe solution to enhance healthy cognitive function through scientifically-validated technology with high quality, powerful ingredients.* Our dynamic Korea market is the perfect place to launch this Mannatech product for the first time. I am convinced that their desire for more progressive and innovative wellness solutions will accelerate the reception of this product throughout Korea, and ultimately, the world.”

Cognitate is set to launch on October 31, 2015 at Mannatech’s Asia MannaFest event in Seoul. Asia MannaFest is Mannatech’s biggest global annual event and is expected to welcome more than 10,000 guests. Mannatech leaders will share their stories of success, provide real business and product training and the company will recognize Associates who have achieved new levels of sales accomplishment and leadership in the past year. Cognitate will be available to order at the event and additional Cognitate formulations will launch in other global markets in 2016.

For more information on Cognitate in Korea, please visit kr.Mannatech.com.

About Mannatech

Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing childhood nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea, Mexico, Namibia, Spain and Hong Kong. For more information, visit Mannatech.com.

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

*Product claims are specific to Korea Cognitate formulation.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151006006250/en/

CONTACT

Mannatech, Incorporated
Raquel Mooring, 972-471-1532
pr@mannatech.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease